Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

AstraZeneca Announces New Genome Editing Collaborations

January 29, 2015 9:21 am | News | Comments

AstraZeneca announced four research collaborations aimed at harnessing the power of CRISPR, a pioneering genome-editing technique, across its entire discovery platform in the company’s key therapeutic areas. Read more...       


Rotavirus Vaccine Reduces Severe Diarrhea by 64 Percent

January 29, 2015 9:12 am | by University of Liverpool | News | Comments

Researchers have found that diarrhoea caused by rotavirus infection is significantly reduced in the developing world with the use of a vaccine to prevent the condition. Read more...             


Roche, Qualcomm to Collaborate on Remote Patient Monitoring

January 29, 2015 9:04 am | News | Comments

This is a strategic collaboration to improve remote monitoring and management of chronic disease patients. Read more...                        


New Method for Identifying Aggressive Childhood Cancers

January 29, 2015 8:58 am | by Lund University | News | Comments

When a cancerous cell divides, the chromosomes often end up in the wrong place, or break and combine in incorrect ways. Read more....                     


Atlas Genetics Completes $20M Series C Fundraising

January 29, 2015 8:54 am | News | Comments

Atlas develops ultra-rapid point-of-care diagnostic tests for infectious diseases. Read more...                            


WHO: Ebola Response Shifts to Ending Epidemic

January 29, 2015 8:47 am | by Maria Cheng - AP Medical Writer | News | Comments

Health officials are now focused on ending the biggest-ever Ebola outbreak rather than just slowing the deadly virus' spread, the World Health Organization said Thursday. Read more...             


Dr. Oz and the Weight Loss Claim Controversy

January 28, 2015 5:14 pm | by Ryan Bushey, Associate Editor | Articles | Comments

A guest that has appeared on The Doctor Oz show was at the center of a lawsuit filed by the FTC. Read more...                        


U.S. Measles Outbreak Hits 87 Cases and Counting

January 28, 2015 12:33 pm | by Stephanie Guzowski, Editor | Articles | Comments

The measles outbreak, which originated at Disneyland, continues to expand, with 87 confirmed cases in people ranging in ages from 7 months to 70 years. Read more...                                     


Swiss Drug Maker Novartis Posts Q4 Profit Drop

January 28, 2015 12:04 pm | by Associated Press | News | Comments

Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit. Read more...                                 


Possible Therapeutic Target for Brain Blood Vessel Disorder

January 28, 2015 11:56 am | by University of Pennsylvania | News | Comments

Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, strokes, hemorrhages, and other serious conditions, yet their precise molecular cause has never been determined. Read more...


Drug Candidates Can Block Cell-Death Parkinson's Pathway

January 28, 2015 11:49 am | by Scripps Research Institute | News | Comments

In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's disease. Read more...

Drug Combo Suppresses Late-Stage Prostate Cancer Growth

January 28, 2015 11:37 am | by Purdue University | News | Comments

Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors, a Purdue University study finds. Read more...                          


IntelliCell BioSciences Licenses Indication for Diabetes to Invigorcell

January 28, 2015 11:32 am | by IntelliCell BioSciences | News | Comments

IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company"), a regenerative medicine company utilizing adult autologous stromal vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced a license agreement for the indication of Diabetes Mellitus. Read more...


Diet and Nutrition Essential for Mental Health

January 28, 2015 9:18 am | by University of Melbourne | News | Comments

Evidence is rapidly growing showing vital relationships between both diet quality and potential nutritional deficiencies and mental health. Read more....                  


Scientists Find Potential Anti-Cancer Use for Anti-Epilepsy Drug

January 28, 2015 9:11 am | by University of York | News | Comments

Scientists studied phenytoin, a drug which inhibits epilepsy by targeting sodium channels. Read more...                          



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.